ConductScience.org, home

Trial · NCT00981799

Participant flow12

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDNelarabine Dose Level 16
Overall StudySTARTEDNelarabine Dose Level 27
Overall StudySTARTEDNelarabine Dose Level 310
Overall StudySTARTEDNelarabine Dose Level 00
Overall StudyCOMPLETEDNelarabine Dose Level 15
Overall StudyCOMPLETEDNelarabine Dose Level 26
Overall StudyCOMPLETEDNelarabine Dose Level 310
Overall StudyCOMPLETEDNelarabine Dose Level 00
Overall StudyNOT COMPLETEDNelarabine Dose Level 11
Overall StudyNOT COMPLETEDNelarabine Dose Level 21
Overall StudyNOT COMPLETEDNelarabine Dose Level 30
Overall StudyNOT COMPLETEDNelarabine Dose Level 00

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00981799/flow